{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for m root_names_stdName in Standardized Name (approximate match)
Status:
Investigational
Source:
INN:precemtabart tocentecan [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:ziralimumab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:efzimfotase alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:telpegfilgrastim [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04553692: Phase 1 Interventional Active, not recruiting Solid Tumor
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04669015: Phase 3 Interventional Unknown status Covid19
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:miromavimab [INN]
Source URL:
Class:
PROTEIN